Hoth Therapeutics (NASDAQ:HOTH) has entered into an exclusive licensing agreement to develop potential anti-obesity treatments based on technology co-developed by Emory University and the U.S ...

(RTTNews) - Hoth Therapeutics (HOTH) has entered into an exclusive patent license agreement with the U.S. Department of Veterans Affairs, providing the company with exclusive rights to a jointly ...

The Company affirms that it has no plans for a public or private offering at this time. Hoth's financial position remains robust, with a strong balance sheet that includes over $10 million in cash ...

Hoth Therapeutics (NASDAQ:HOTH) shares rose by a staggering 215% today following significant breakthrough in cancer treatment. Their Phase 2a clinical trial of Hoth's topical gel HT-001 has shown ...

Hoth Therapeutics (HOTH) announced that it has entered into an exclusive patent license agreement with the U.S. Department of Veterans Affairs. This agreement provides Hoth with exclusive rights ...